U.S., May 15 -- ClinicalTrials.gov registry received information related to the study (NCT07585695) titled 'Coronary Artery Disease Screening in Patients With Chronic Kidney Disease' on May 06.
Brief Summary: Patients with chronic kidney disease (CKD) have a markedly increased cardiovascular risk, with coronary artery disease being a leading cause of morbidity and mortality. Conventional cardiovascular risk scores and non-invasive diagnostic tests have limited accuracy in this population, partly due to atypical symptoms and frequent structural heart disease. Coronary flow reserve (CFR) is a key marker of coronary microvascular dysfunction and has strong prognostic value, but its assessment is usually limited to invasive techniques. Recent ...